Catherine A. Cosgrove, PhD

Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George’s University of London, United Kingdom

Poster(s):

• (2363) Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET